Terms: = Endocrine gland cancer AND SYK, P43405, 6850, ENSG00000165025
29 results:
1. syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy.
Zhou Q; Tu X; Hou X; Yu J; Zhao F; Huang J; Kloeber J; Olson A; Gao M; Luo K; Zhu S; Wu Z; Zhang Y; Sun C; Zeng X; Schoolmeester KJ; Weroha JS; Hu X; Jiang Y; Wang L; Mutter RW; Lou Z
Drug Resist Updat; 2024 May; 74():101085. PubMed ID: 38636338
[TBL] [Abstract] [Full Text] [Related]
2. Spleen tyrosine kinase facilitates the progression of papillary thyroid cancer regulated by the hsa_circ_0006417/miR-377-3p axis.
Tan G; Zheng S; Zhou B; Mo Z; Zhang Q; Zhang D; Li A; Liu X
Environ Toxicol; 2024 Jan; 39(1):421-434. PubMed ID: 37792549
[TBL] [Abstract] [Full Text] [Related]
3. syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma.
Rohila D; Park IH; Pham TV; Weitz J; Hurtado de Mendoza T; Madheswaran S; Ishfaq M; Beaman C; Tapia E; Sun S; Patel J; Tamayo P; Lowy AM; Joshi S
Cancer Res; 2023 Aug; 83(16):2675-2689. PubMed ID: 37306759
[TBL] [Abstract] [Full Text] [Related]
4. Is the radiomics-clinical combined model helpful in distinguishing between pancreatic cancer and mass-forming pancreatitis?
Qu W; Zhou Z; Yuan G; Li S; Li J; Chu Q; Zhang Q; Xie Q; Li Z; Kamel IR
Eur J Radiol; 2023 Jul; 164():110857. PubMed ID: 37172441
[TBL] [Abstract] [Full Text] [Related]
5. Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer.
Liang T; Wu X; Wang L; Ni Z; Fan Y; Wu P; Wang H; Niu Y; Huang H
Pathol Res Pract; 2023 May; 245():154431. PubMed ID: 37060824
[TBL] [Abstract] [Full Text] [Related]
6. Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling.
Lu Q; Nie R; Luo J; Wang X; You L
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671489
[TBL] [Abstract] [Full Text] [Related]
7. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
8. Special issue "The advance of solid tumor research in China": Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors.
Chen L; Wang W; Jin K; Yuan B; Tan H; Sun J; Guo Y; Luo Y; Feng ST; Yu X; Chen MH; Chen J
Int J Cancer; 2023 Jan; 152(1):90-99. PubMed ID: 36111424
[TBL] [Abstract] [Full Text] [Related]
9. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer.
Li TJ; Jin KZ; Li H; Ye LY; Li PC; Jiang B; Lin X; Liao ZY; Zhang HR; Shi SM; Lin MX; Fei QL; Xiao ZW; Xu HX; Liu L; Yu XJ; Wu WD
Cancer Lett; 2022 Apr; 530():142-155. PubMed ID: 35077803
[TBL] [Abstract] [Full Text] [Related]
10. Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma.
Yoshida K; Yokoi A; Matsuzaki J; Kato T; Ochiya T; Kajiyama H; Yamamoto Y
Cancer Sci; 2021 Dec; 112(12):4977-4986. PubMed ID: 34618992
[TBL] [Abstract] [Full Text] [Related]
11. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
Front Immunol; 2021; 12():670642. PubMed ID: 34248951
[TBL] [Abstract] [Full Text] [Related]
12. DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis.
Deng J; Kang Y; Cheng CC; Li X; Dai B; Katz MH; Men T; Kim MP; Koay EA; Huang H; Brekken RA; Fleming JB
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34237033
[TBL] [Abstract] [Full Text] [Related]
13. Thyroid nodule recognition using a joint convolutional neural network with information fusion of ultrasound images and radiofrequency data.
Liu Z; Zhong S; Liu Q; Xie C; Dai Y; Peng C; Chen X; Zou R
Eur Radiol; 2021 Jul; 31(7):5001-5011. PubMed ID: 33409774
[TBL] [Abstract] [Full Text] [Related]
14. Transcriptome sequencing identifies genes associated with invasion of ovarian cancer.
Peng X; Yu M; Chen J
J Int Med Res; 2020 Sep; 48(9):300060520950912. PubMed ID: 32878513
[TBL] [Abstract] [Full Text] [Related]
15. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
[TBL] [Abstract] [Full Text] [Related]
16. Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer.
Yu Y; Suryo Rahmanto Y; Shen YA; Ardighieri L; Davidson B; Gaillard S; Ayhan A; Shi X; Xuan J; Wang TL; Shih IM
EBioMedicine; 2019 Sep; 47():184-194. PubMed ID: 31492560
[TBL] [Abstract] [Full Text] [Related]
17. Expression of syk and MAP4 proteins in ovarian cancer.
Zhang S; Deen S; Storr SJ; Yao A; Martin SG
J Cancer Res Clin Oncol; 2019 Apr; 145(4):909-919. PubMed ID: 30737623
[TBL] [Abstract] [Full Text] [Related]
18. The syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance.
Duran GE; Sikic BI
PLoS One; 2019; 14(1):e0210879. PubMed ID: 30668583
[TBL] [Abstract] [Full Text] [Related]
19. Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells.
Park GB; Chung YH; Kim D
Oncol Rep; 2017 May; 37(5):3137-3145. PubMed ID: 28350104
[TBL] [Abstract] [Full Text] [Related]
20. Nomogram for predicting central node metastasis in papillary thyroid carcinoma.
Kim SK; Chai YJ; Park I; Woo JW; Lee JH; Lee KE; Choe JH; Kim JH; Kim JS
J Surg Oncol; 2017 Mar; 115(3):266-272. PubMed ID: 27859312
[TBL] [Abstract] [Full Text] [Related]
[Next]